Show simple item record

dc.contributor.authorBerliner, Elizabeth
dc.date.accessioned2005-11-23T17:56:00Z
dc.date.available2005-11-23T17:56:00Z
dc.date.issued2003-02-05
dc.identifier.urihttps://hdl.handle.net/1813/2523
dc.descriptionSenior seminar (D.V.M.) -- Cornell University, 2003. Includes bibliographical references (leaves 12-13).en_US
dc.description.abstractSplenic mast cell tumor is the most common splenic neoplasm in the cat. This disease is frequently metastatic, involving liver, lymph node, and bone marrow, with a peripheral mastocythemia. The treatment of choice is splenectomy, with surprisingly long survival times (mean of 12-19 months) considering the extent of metastatic disease. There are currently no proven chemotherapeutic options for cats, although recent research suggests CCNU may be useful post-operatively.en_US
dc.description.sponsorshipAdvisor: Dr. Dennis Bailey Clinicians: Dr. Olivier Toulza, Dr. Michelle Steffeyen_US
dc.format.extent111364 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.relation.ispartofseriesSenior seminar paper
dc.relation.ispartofseriesSeminar SF610.1 2003 B47
dc.subjectCats -- Diseases -- Case studiesen_US
dc.titleFeline splenic mast cell tumoren_US
dc.typeterm paperen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Statistics